Embryonal tumors are rare malignant neoplasms that develop from cells involved in tissue formation during the early stages of embryonic development. These tumors most commonly occur in young children and can arise in various organs, including the brain, kidneys, liver, and other tissues. The most well-known types of embryonal tumors include neuroblastoma, medulloblastoma, hepatoblastoma, and Wilms tumor (nephroblastoma). Treatment depends on the tumor type, its location, the stage of the disease, and the child’s age.
Main treatment methods for embryonal tumors in Belarus
- Surgical removal. Surgery plays a key role in the treatment of many embryonal tumors. The goal of surgery is complete tumor removal whenever possible, while preserving vital structures. In certain tumors, such as Wilms tumor or hepatoblastoma, surgery may involve removal of the affected organ (for example, a kidney or part of the liver), followed by measures to maintain normal body function.
- Chemotherapy. Chemotherapy is used to destroy cancer cells and to reduce tumor size before surgery or after surgery to eliminate residual malignant cells. In some cases, chemotherapy is the primary treatment method, especially when the tumor cannot be safely removed surgically. Drug combinations are selected based on tumor type and sensitivity. Medications are administered intravenously, and treatment is given in cycles.
- Radiation therapy. Radiation therapy is used to treat embryonal tumors such as medulloblastoma, particularly when complete surgical removal is not possible or when there is a risk of cancer cell spread. Radiation techniques and doses are carefully selected according to the child’s age and tumor location, as radiation may affect growth and development.
- Targeted therapy and immunotherapy. In recent years, targeted therapies have been studied for the treatment of embryonal tumors. These therapies act on specific molecular pathways involved in tumor growth and proliferation. Immunotherapy stimulates the body’s immune system to fight cancer cells; an example is the use of antibodies directed against tumor-specific proteins, such as in the treatment of neuroblastoma.
Treatment by type of embryonal tumor
Neuroblastoma
- Most commonly affects the adrenal glands and the sympathetic nervous system. Treatment depends on stage and risk group.
- Low risk: surgical removal of the tumor; in some cases, observation without additional therapy.
- Intermediate risk: surgery combined with chemotherapy to reduce the risk of recurrence.
- High risk: intensive chemotherapy, surgical removal, radiation therapy, stem cell transplantation, and immunotherapy.
Medulloblastoma
- A brain tumor most often located in the cerebellum. Treatment includes surgical removal, radiation therapy, and chemotherapy.
- In very young children (under 3 years of age), radiation therapy is avoided whenever possible due to the risk of impaired brain development, and chemotherapy is prioritized.
Wilms tumor (nephroblastoma)
- A malignant kidney tumor most commonly seen in children under 5 years of age. Treatment usually includes surgical removal of the affected kidney, chemotherapy, and in some cases radiation therapy.
- Prognosis depends on tumor stage and extent of spread, but with early detection, survival rates are high.
Hepatoblastoma
- A rare liver tumor occurring in young children. Treatment includes surgical tumor removal, chemotherapy before and after surgery, and in some cases liver transplantation.
Stages of treatment
- Diagnosis. Includes comprehensive evaluation such as CT, MRI, biopsy, blood tests, and genetic tumor analysis. These investigations help determine tumor type, size, and stage.
- Neoadjuvant therapy. Chemotherapy or radiation therapy administered before surgery to reduce tumor size and facilitate safer removal.
- Surgical treatment. If the tumor can be safely removed, surgery is performed as early as possible, with efforts to minimize damage to healthy tissues.
- Adjuvant therapy. Chemotherapy or radiation therapy after surgery to eliminate residual cancer cells and prevent recurrence.
Factors influencing a favorable treatment outcome
- Tumor type and stage. Earlier detection is associated with a better prognosis. For example, Wilms tumor and neuroblastoma have high survival rates when treated early.
- Child’s age. In some cases, younger age may be either a favorable or unfavorable factor depending on tumor biology and treatment sensitivity.
- Response to therapy. A rapid and positive response to chemotherapy or radiation therapy is associated with improved long-term outcomes.
- Genetic features of the tumor. Certain genetic mutations may influence treatment selection and prognosis.
Treatment of embryonal tumors in children requires a comprehensive approach that includes surgery, chemotherapy, radiation therapy, and in some cases targeted and immunotherapeutic methods. Early diagnosis and appropriately selected treatment significantly increase the chances of recovery. Each case is unique, and therapy must be tailored to the individual needs of the child. Family support, rehabilitation, and regular medical follow-up play a crucial role in successful treatment and recovery.
